Trial NCT00555464

View at ClinicalTrials.gov 
Org. Study IDs: 3429
Secondary IDs: #FDA-R-003429-01

Last trial update was posted on 2013-06-11

MeSH Interventions

Methylprednisolone Methylprednisolone Acetate Methylprednisolone Hemisuccinate Prednisolone Prednisolone acetate Prednisolone hemisuccinate Prednisolone phosphate Prednisone Vincristine

MeSH Conditions

Hemangioma

Other Conditions


Stopping Reasons

The introduction of oral propranolol as a highly efficacious agent for infantile hemangiomas

Limitations And Caveats

The limitations of this trial include early termination of enrollment leading to small numbers of subjects analyzed.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID